Key Takeaways
- Who: Beijing‑based robotics startup Linkerbot, the global leader in dexterous robotic hands for humanoid robots.
- What: The company will seek a $6 billion valuation in its next financing round, double the $3 billion valuation it just secured in a Series B+ round.
- Why: Linkerbot wants to scale manufacturing, R&D, and global partnerships as humanoid deployments ramp and demand for high‑degree‑of‑freedom hands soars.
- Track record: Has shipped more than 10,000 dexterous hands, produced over 1,000 high‑DoF hands per month, and raised over $150M since 2025.
What Happened?
Chinese robotics startup Linkerbot has announced it will target a $6 billion valuation in its next funding round, a move that would double the $3 billion valuation it secured in a recently closed Series B+ round. The company, based in Beijing and known for building highly dexterous robotic hands for humanoid platforms, disclosed the plan in a statement covered by Reuters, which noted that the timing and exact route (private round vs IPO) have not yet been finalized.
What a $6B Target Means
Aiming for a $6 billion valuation signals that Linkerbot sees itself not as a niche component supplier, but as a core infrastructure layer for the global humanoid‑robot supply chain. The startup already positions itself as the market leader in high‑degree‑of‑freedom robotic hands, having shipped more than 10,000 units and ramped to over 1,000 dexterous hands per month, a scale few competitors have matched.
On the financial side, Linkerbot’s Series B+ round last week valued it at $3 billion, with participation from major Chinese institutions such as Bank of China Asset Management and Fosun Capital, alongside earlier backers like Ant Group and HongShan Group. The jump to a $6B target implies expectations for massive revenue growth, driven by long‑term contracts with humanoid OEMs, higher‑volume manufacturing, and possibly white‑labeling or licensing of its hand actuation and software stack.
Broader Market Context
At a time when global tech giants, electric‑car makers, and startups are racing to field humanoid robots for logistics, warehousing, and service‑industry roles, a reliable, high‑performance robotic hand is a strategic bottleneck. Linkerbot’s push for a $6B valuation reflects how much value is being assigned to “hand‑equivalent” dexterity—without it, many humanoid hardware stacks are functionally limited.
On the competitive front, the company faces challengers in China such as PickPlace and Shadow Robot‑style industrial‑hand vendors, but Linkerbot’s mass‑production capability and 80%+ share in the high‑DoF segment give it a strong moat. Regulators and investors are also watching how China’s robotics and AI strategies intersect with export controls, dual‑use concerns, and U.S.‑China tech‑competition dynamics, which could shape how freely Linkerbot can sell its hand modules to Western OEMs in the coming years.
Competitive Comparison Table
The “competitors” are other high‑dexterity robotic‑hand and humanoid‑hand‑platform players at a similar scale. Two relevant peers are:
- PickPlace – Chinese‑based dexterous‑hand and gripper‑focused startup targeting industrial‑automation and humanoids.
- Shadow Robot Company (or a comparable mid‑tier European‑style dexterous‑hand vendor) – Known for high‑DoF robotic hands, though more niche and lower‑volume than Linkerbot.
Competitive Comparison
| Feature / Metric | Linkerbot | PickPlace | Shadow‑style hand vendor |
| Target valuation (approx.) | $6B (target), $3B (current) | Likely low‑hundreds of millions (est.) | Likely sub‑$1B private or academia‑linked |
| Monthly hand output (approx.) | >1,000 high‑DoF hands | Tens‑to‑low‑hundreds scale (est.) | Low‑volume, bespoke |
| Market positioning | Mass‑production leader for humanoids | Industrial‑gripper & mid‑DoF hand vendor | High‑DoF research / specialty‑gripper hands |
| Backer profile | Ant Group, HongShan, BOC Asset Mgmt, Fosun | Smaller‑ticket VC / industrial backers (typical) | Mix of research‑grant and niche‑industrial capital |
Strategic analysis
- Linkerbot wins on scale and valuation momentum, making it the most attractive “off‑the‑shelf” hand supplier for high‑volume humanoid‑OEM programs betting on mass deployment.
- PickPlace and Shadow‑style vendors remain more niche, winning in specialized industrial‑gripper or research‑robotics segments, but they lack the proven mass‑production depth and billion‑dollar‑backed balance‑sheet muscle Linkerbot now wields.
Author’s Takeaway
In my experience covering robotics and AI‑hardware deals, a $6B valuation target for a four‑year‑old component‑focused startup like Linkerbot is a strong bullish signal for the entire humanoid‑robot stack. What Linkerbot is effectively telling investors is that dexterous hands are no longer a “nice‑to‑have” add‑on but a mission‑critical subsystem—so much so that it can justify a unicorn‑on‑steroids valuation even before the broader humanoid market is fully mature.
I think this is a very bullish move for the robotics‑supply‑chain ecosystem, especially for Chinese hardware makers who can now argue that specialized actuation and hand technologies command premium valuations and can pull in capital from global tech‑focused funds. For end users—whether humanoid OEMs, logistics chains, or industrial‑automation integrators—this means more competition‑driven innovation in hand design, reliability, and cost, which could accelerate the pace at which humanoids move from lab demos to real‑world warehouses, hospitals, and factories.
That said, I’m cautious about the regulatory and geopolitical risk baked into a Chinese‑led, high‑dexterity‑hand champion. As U.S. and European regulators scrutinize dual‑use robotics components, any restrictions on exports or licensing could fragment the global supply chain and force OEMs to maintain duplicate hand‑sourcing strategies (China vs. Western‑based suppliers).
Overall, I see Linkerbot’s $6B‑target push as a clear vote of confidence in the “hand‑centric” phase of humanoid economics: if the hands are good, scalable, and financially backed, the rest of the robot can follow. For investors, it’s a reminder that the next wave of robotics value may sit not in the torso, but in the fingertips.